March 13, 2026

Guaranteed payment for high value transactions in Dubai

Finseta helps businesses and individuals arrange bank guaranteed manager’s cheques in Dubai, providing a secure payment method for property purchases and other high value transactions...

Brava Health builds for the next phase of health and wellness

Brava Health is building tools that shift healthcare from access to proactive health optimisation...

Retail’s margin problem is forcing a new profit model

itim argues that retailers must adopt a more efficient, customer focused operating model if they are to move from sub five per cent margins towards sustainable..

Emergent BioSolutions Inc. (EBS) Investor Outlook: Analyzing a 47.6% Potential Upside

Emergent BioSolutions Inc. (NYSE: EBS), a key player in the healthcare sector, specializes in providing preparedness and response solutions for public health threats. With a market..

Maze Therapeutics, Inc. (MAZE): Investor Outlook and Analyst Ratings Point to Strong Growth Potential

Maze Therapeutics, Inc. (NASDAQ: MAZE) is capturing the attention of investors with a compelling blend of innovation in the biotechnology sector and promising analyst ratings. Headquartered..

Standard BioTools Inc. (LAB) Stock Analysis: Exploring a 66.58% Potential Upside in the Medical Devices Sector

Standard BioTools Inc. (NASDAQ: LAB), a noteworthy player in the healthcare sector specializing in medical devices, offers a tantalizing prospect for investors with its potential upside..

Tectonic Therapeutic, Inc. (TECX): Investor Outlook on a Biotech Innovator with a 129% Upside Potential

Tectonic Therapeutic, Inc. (NASDAQ: TECX) is capturing the attention of investors with its innovative approach in the biotechnology sector, particularly focusing on the modulation of G..

Humacyte, Inc. (HUMA) Stock Analysis: Unveiling a Potential 576% Upside in Biotech

Humacyte, Inc. (NASDAQ: HUMA), a pioneering biotechnology company in the healthcare sector, is capturing investor attention with its ambitious focus on bioengineered human tissues. Based in..

Abivax SA (ABVX): Investor Outlook with a 32.67% Potential Upside and Strong Analyst Support

Abivax SA (ABVX), a France-based biotechnology firm, is currently capturing the attention of investors with its promising potential upside of 32.67%. This clinical-stage company is renowned..

Oruka Therapeutics, Inc. (ORKA) Stock Analysis: 81% Potential Upside Sparks Investor Interest

In the dynamic world of biotechnology, Oruka Therapeutics, Inc. (NASDAQ: ORKA) is rapidly gaining attention. With its focus on developing cutting-edge monoclonal antibody therapeutics for psoriasis..

AngioDynamics, Inc. (ANGO) Investor Outlook: An 80% Upside Potential Amid Strategic Healthcare Innovations

AngioDynamics, Inc. (NASDAQ: ANGO), a key player in the healthcare sector, is making waves with its innovative medical technologies. With a market capitalization of $441.44 million,..

Kamada Ltd. (KMDA) Stock Analysis: Analyst Ratings Project a Promising 49.6% Upside

Kamada Ltd. (NASDAQ: KMDA), a key player in the healthcare sector focusing on plasma-derived protein therapeutics, is drawing investor attention with its promising growth trajectory. Headquartered..

Altimmune, Inc. (ALT) Stock Analysis: Exploring a 378% Potential Upside Amidst Biopharmaceutical Innovation

Altimmune, Inc. (NASDAQ: ALT), a clinical-stage biopharmaceutical company, has been drawing significant attention in the biotechnology sector with its ambitious focus on tackling obesity, metabolic, and..

MeiraGTx Holdings plc (MGTX) Investor Outlook: Exploring a 250% Upside Potential in the Biotechnology Sector

In the dynamic world of biotechnology, few companies offer the tantalizing upside potential that MeiraGTx Holdings plc (NASDAQ: MGTX) does. With a potential upside of 250.13%,..

Bioventus Inc. (BVS) Stock Analysis: Exploring a 74% Potential Upside in the Medical Device Sector

Bioventus Inc. (NASDAQ: BVS), a prominent player in the healthcare sector, is capturing the attention of investors with a notable 74.42% potential upside, according to recent..

Oric Pharmaceuticals, Inc. (ORIC) Stock Analysis: Unveiling an 80.53% Potential Upside for Investors

Oric Pharmaceuticals, Inc. (NASDAQ: ORIC) has been capturing the attention of investors with its promising pipeline and strategic partnerships in the biotechnology sector. As a clinical-stage..

Septerna, Inc. (SEPN) Stock Analysis: Unveiling a Biotech Gem with 65.84% Upside Potential

Septerna, Inc. (NASDAQ: SEPN) stands as a dynamic player in the biotechnology sector, capturing investor attention with a staggering potential upside of 65.84%. As a clinical-stage..

Rapport Therapeutics, Inc. (RAPP) Stock Analysis: 82% Upside Potential Sparks Interest in Biotech Innovator

Investors focusing on the biotechnology sector might want to take a closer look at Rapport Therapeutics, Inc. (NASDAQ: RAPP), a clinical-stage biopharmaceutical company that has been..

SIGA Technologies Inc. (SIGA) Stock Analysis: Navigating the Health Security Market Amid Revenue Challenges

Investors eyeing SIGA Technologies Inc. (NASDAQ: SIGA) should consider both its potential and challenges within the healthcare sector. As a commercial-stage pharmaceutical company specializing in health..

Talkspace, Inc. (TALK) Stock Analysis: Navigating a 19.42% Potential Upside in the Digital Health Arena

Talkspace, Inc. (NASDAQ: TALK) is making waves in the digital healthcare sector, offering a unique investment opportunity as it continues to expand its footprint in the..

Search

Funds

March 13, 2026

Guaranteed payment for high value transactions in Dubai

Finseta helps businesses and individuals arrange bank guaranteed manager’s cheques in Dubai, providing a secure payment method for property purchases and other high value transactions...

Brava Health builds for the next phase of health and wellness

Brava Health is building tools that shift healthcare from access to proactive health optimisation...

Retail’s margin problem is forcing a new profit model

itim argues that retailers must adopt a more efficient, customer focused operating model if they are to move from sub five per cent margins towards sustainable ten per cent net profitability...
Search

Funds

March 13, 2026

FTSE 100

Funds